| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 28 | 2020 | 955 | 3.390 |
Why?
|
| Genome-Wide Association Study | 27 | 2020 | 1621 | 1.680 |
Why?
|
| Polymorphism, Single Nucleotide | 36 | 2020 | 2357 | 1.670 |
Why?
|
| Genetic Predisposition to Disease | 20 | 2019 | 2270 | 1.430 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 294 | 1.010 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2018 | 39 | 0.980 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 150 | 0.940 |
Why?
|
| Shock | 1 | 2023 | 42 | 0.900 |
Why?
|
| Evolution, Molecular | 7 | 2012 | 813 | 0.860 |
Why?
|
| Genetic Loci | 11 | 2019 | 250 | 0.850 |
Why?
|
| Spermatozoa | 3 | 2006 | 62 | 0.720 |
Why?
|
| Indians, North American | 3 | 2017 | 48 | 0.660 |
Why?
|
| Genome, Human | 8 | 2016 | 756 | 0.650 |
Why?
|
| Alleles | 10 | 2020 | 1128 | 0.620 |
Why?
|
| Genetic Variation | 8 | 2017 | 1351 | 0.590 |
Why?
|
| Gene Frequency | 10 | 2017 | 677 | 0.560 |
Why?
|
| Bronchiolitis, Viral | 1 | 2015 | 4 | 0.550 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 36 | 0.540 |
Why?
|
| Infant, Premature | 4 | 2023 | 290 | 0.540 |
Why?
|
| Genotype | 15 | 2020 | 1851 | 0.490 |
Why?
|
| X Chromosome | 2 | 2006 | 152 | 0.490 |
Why?
|
| Electronic Health Records | 1 | 2017 | 319 | 0.460 |
Why?
|
| Genetics, Population | 6 | 2020 | 394 | 0.460 |
Why?
|
| Humans | 69 | 2023 | 86617 | 0.450 |
Why?
|
| Psychodidae | 3 | 2003 | 6 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2014 | 125 | 0.440 |
Why?
|
| Proteins | 4 | 2014 | 777 | 0.440 |
Why?
|
| Selection, Genetic | 5 | 2013 | 502 | 0.430 |
Why?
|
| Immunoglobulin E | 3 | 2020 | 144 | 0.410 |
Why?
|
| Mexican Americans | 4 | 2020 | 63 | 0.410 |
Why?
|
| Male | 39 | 2020 | 40958 | 0.390 |
Why?
|
| Pulmonary Surfactants | 2 | 2021 | 19 | 0.360 |
Why?
|
| Child | 16 | 2018 | 6926 | 0.350 |
Why?
|
| Female | 38 | 2020 | 44509 | 0.350 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2014 | 375 | 0.350 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 148 | 0.330 |
Why?
|
| Adaptation, Physiological | 2 | 2012 | 306 | 0.320 |
Why?
|
| Chromosome Mapping | 8 | 2018 | 1074 | 0.320 |
Why?
|
| Biological Evolution | 2 | 2006 | 919 | 0.320 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 819 | 0.310 |
Why?
|
| Infant, Newborn | 4 | 2023 | 2378 | 0.310 |
Why?
|
| Lung | 3 | 2019 | 1170 | 0.310 |
Why?
|
| Lung Transplantation | 2 | 2019 | 175 | 0.300 |
Why?
|
| Models, Genetic | 4 | 2018 | 926 | 0.280 |
Why?
|
| Albuterol | 2 | 2018 | 35 | 0.280 |
Why?
|
| Bronchodilator Agents | 2 | 2018 | 65 | 0.270 |
Why?
|
| Adolescent | 16 | 2018 | 8979 | 0.270 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 55 | 0.270 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 103 | 0.270 |
Why?
|
| Fertility | 1 | 2005 | 115 | 0.260 |
Why?
|
| Infant | 3 | 2023 | 3045 | 0.260 |
Why?
|
| Cost-Benefit Analysis | 2 | 1997 | 451 | 0.250 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 100 | 0.250 |
Why?
|
| Case-Control Studies | 6 | 2019 | 1804 | 0.240 |
Why?
|
| Testis | 1 | 2004 | 152 | 0.240 |
Why?
|
| Environmental Exposure | 2 | 2017 | 296 | 0.240 |
Why?
|
| Gene Duplication | 1 | 2004 | 125 | 0.240 |
Why?
|
| Hydrocortisone | 2 | 2023 | 298 | 0.240 |
Why?
|
| Haplotypes | 6 | 2020 | 642 | 0.240 |
Why?
|
| Disease | 2 | 2017 | 90 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 319 | 0.230 |
Why?
|
| Metabolome | 1 | 2023 | 47 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2019 | 110 | 0.220 |
Why?
|
| Mutagenesis | 1 | 2002 | 199 | 0.210 |
Why?
|
| Insect Vectors | 2 | 2003 | 9 | 0.200 |
Why?
|
| Enzymes | 1 | 2001 | 47 | 0.200 |
Why?
|
| Budesonide | 1 | 2021 | 45 | 0.190 |
Why?
|
| Metabolomics | 1 | 2021 | 68 | 0.190 |
Why?
|
| Drosophila | 1 | 2004 | 498 | 0.190 |
Why?
|
| Risk | 4 | 2018 | 674 | 0.190 |
Why?
|
| Odds Ratio | 3 | 2017 | 678 | 0.190 |
Why?
|
| United States | 11 | 2020 | 6665 | 0.180 |
Why?
|
| Nitric Oxide | 2 | 2018 | 278 | 0.180 |
Why?
|
| HLA-DRB1 Chains | 1 | 2020 | 28 | 0.180 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1999 | 4 | 0.180 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 14 | 0.180 |
Why?
|
| Primary Graft Dysfunction | 1 | 2019 | 27 | 0.180 |
Why?
|
| Lectins, C-Type | 1 | 2019 | 85 | 0.180 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2019 | 34 | 0.170 |
Why?
|
| Risk Factors | 7 | 2018 | 5417 | 0.170 |
Why?
|
| Genomics | 2 | 2015 | 720 | 0.170 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 159 | 0.170 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2018 | 5 | 0.170 |
Why?
|
| Telomere | 1 | 2019 | 108 | 0.170 |
Why?
|
| Allografts | 1 | 2019 | 172 | 0.170 |
Why?
|
| Smad2 Protein | 1 | 2018 | 17 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2018 | 42 | 0.170 |
Why?
|
| HLA Antigens | 1 | 2020 | 232 | 0.160 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2018 | 43 | 0.160 |
Why?
|
| Gene Flow | 2 | 2016 | 88 | 0.160 |
Why?
|
| Chromosomes | 1 | 2018 | 96 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 339 | 0.160 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 188 | 0.160 |
Why?
|
| Pharmacogenomic Variants | 1 | 2018 | 41 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1621 | 0.160 |
Why?
|
| Lupus Nephritis | 1 | 2018 | 78 | 0.150 |
Why?
|
| Child, Preschool | 5 | 2015 | 3611 | 0.150 |
Why?
|
| Puerto Rico | 5 | 2016 | 31 | 0.150 |
Why?
|
| Confidence Intervals | 1 | 1997 | 229 | 0.150 |
Why?
|
| GATA3 Transcription Factor | 2 | 2014 | 48 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 263 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2017 | 109 | 0.150 |
Why?
|
| Models, Statistical | 2 | 2017 | 574 | 0.150 |
Why?
|
| Ikaros Transcription Factor | 2 | 2014 | 25 | 0.150 |
Why?
|
| Animals | 11 | 2016 | 26582 | 0.150 |
Why?
|
| Health Services Research | 1 | 1997 | 136 | 0.150 |
Why?
|
| Tacrolimus | 1 | 2018 | 373 | 0.150 |
Why?
|
| Human Migration | 1 | 2016 | 25 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2017 | 103 | 0.140 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 30 | 0.140 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 473 | 0.140 |
Why?
|
| CD56 Antigen | 1 | 2015 | 18 | 0.140 |
Why?
|
| Software | 2 | 2017 | 654 | 0.140 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2015 | 14 | 0.140 |
Why?
|
| Young Adult | 8 | 2014 | 5974 | 0.140 |
Why?
|
| S100 Proteins | 1 | 2015 | 50 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 334 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2018 | 712 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 266 | 0.130 |
Why?
|
| Genetics, Medical | 1 | 2015 | 52 | 0.130 |
Why?
|
| Genomic Imprinting | 1 | 2015 | 33 | 0.130 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2015 | 41 | 0.130 |
Why?
|
| Air Pollution | 1 | 2016 | 68 | 0.130 |
Why?
|
| Exome | 1 | 2015 | 127 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2017 | 628 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 3 | 2017 | 853 | 0.130 |
Why?
|
| Minority Groups | 1 | 2016 | 137 | 0.130 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 153 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 164 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 115 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 81 | 0.130 |
Why?
|
| Cholecalciferol | 1 | 1994 | 35 | 0.120 |
Why?
|
| DNA-Binding Proteins | 4 | 2014 | 1208 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 170 | 0.120 |
Why?
|
| Rhinitis, Allergic | 1 | 2014 | 43 | 0.120 |
Why?
|
| Founder Effect | 1 | 2014 | 104 | 0.120 |
Why?
|
| Interleukin-4 | 2 | 2016 | 127 | 0.120 |
Why?
|
| Adult | 13 | 2019 | 25640 | 0.120 |
Why?
|
| Hip Fractures | 1 | 1994 | 45 | 0.120 |
Why?
|
| Mice | 6 | 2016 | 11352 | 0.120 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2013 | 9 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 47 | 0.110 |
Why?
|
| Prevalence | 1 | 2017 | 1239 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 567 | 0.110 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2012 | 12 | 0.110 |
Why?
|
| Likelihood Functions | 2 | 2004 | 251 | 0.110 |
Why?
|
| Venezuela | 3 | 2003 | 9 | 0.110 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 532 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1997 | 864 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2019 | 2767 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 977 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2012 | 17 | 0.110 |
Why?
|
| Kallikreins | 1 | 2012 | 47 | 0.110 |
Why?
|
| RNA | 2 | 2019 | 560 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 59 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2016 | 409 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2014 | 300 | 0.110 |
Why?
|
| Mutation | 2 | 2019 | 3967 | 0.110 |
Why?
|
| Untranslated Regions | 1 | 2012 | 19 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2018 | 1065 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 311 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2014 | 370 | 0.100 |
Why?
|
| Multigene Family | 1 | 2012 | 202 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 296 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2012 | 117 | 0.100 |
Why?
|
| Caribbean Region | 1 | 2011 | 20 | 0.100 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 4 | 0.100 |
Why?
|
| Computational Biology | 1 | 2015 | 528 | 0.100 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2011 | 9 | 0.100 |
Why?
|
| North America | 1 | 2011 | 180 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2014 | 1565 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 268 | 0.090 |
Why?
|
| United Kingdom | 3 | 2007 | 164 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 353 | 0.090 |
Why?
|
| Exons | 1 | 2012 | 450 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2012 | 241 | 0.090 |
Why?
|
| Phenotype | 4 | 2018 | 2378 | 0.090 |
Why?
|
| Introns | 3 | 2018 | 289 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 439 | 0.090 |
Why?
|
| Mexico | 3 | 2015 | 67 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2015 | 258 | 0.080 |
Why?
|
| Algorithms | 2 | 2015 | 1830 | 0.080 |
Why?
|
| Middle Aged | 8 | 2020 | 25017 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 2009 | 197 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2007 | 48 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1920 | 0.070 |
Why?
|
| Genes, Essential | 1 | 2005 | 19 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1384 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1961 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2007 | 280 | 0.060 |
Why?
|
| Gene Expression | 1 | 2009 | 1284 | 0.060 |
Why?
|
| Codon | 1 | 2004 | 124 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 297 | 0.060 |
Why?
|
| Demography | 3 | 2009 | 177 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2007 | 339 | 0.060 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2003 | 6 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2014 | 49 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2007 | 371 | 0.060 |
Why?
|
| Aged | 5 | 2020 | 18402 | 0.060 |
Why?
|
| Base Sequence | 3 | 2016 | 2330 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 479 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2705 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 3030 | 0.060 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 2001 | 3 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 1185 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 339 | 0.050 |
Why?
|
| Sex Factors | 2 | 2015 | 1054 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2021 | 20 | 0.050 |
Why?
|
| Reproduction | 1 | 2002 | 195 | 0.050 |
Why?
|
| Dried Blood Spot Testing | 1 | 2021 | 10 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 104 | 0.050 |
Why?
|
| Exoribonucleases | 1 | 2019 | 9 | 0.050 |
Why?
|
| Histocompatibility Testing | 1 | 2020 | 154 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2015 | 1078 | 0.040 |
Why?
|
| Telomerase | 1 | 2019 | 55 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3990 | 0.040 |
Why?
|
| Low Back Pain | 1 | 1999 | 40 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2019 | 79 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2019 | 65 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 1999 | 80 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1999 | 271 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2019 | 85 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2018 | 59 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 839 | 0.040 |
Why?
|
| Histone Code | 1 | 2017 | 19 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 476 | 0.040 |
Why?
|
| Planning Techniques | 1 | 1997 | 10 | 0.040 |
Why?
|
| Budgets | 1 | 1997 | 10 | 0.040 |
Why?
|
| State Medicine | 1 | 1997 | 12 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2018 | 326 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2018 | 122 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 388 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 1997 | 58 | 0.040 |
Why?
|
| DNA, Intergenic | 1 | 2016 | 25 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 179 | 0.040 |
Why?
|
| Leukocytes | 1 | 2017 | 202 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 1997 | 80 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 62 | 0.040 |
Why?
|
| Protein S | 1 | 2016 | 1 | 0.040 |
Why?
|
| Nippostrongylus | 1 | 2016 | 4 | 0.040 |
Why?
|
| Strongylida Infections | 1 | 2016 | 7 | 0.040 |
Why?
|
| Pyroglyphidae | 1 | 2016 | 14 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2018 | 352 | 0.040 |
Why?
|
| Phylogeny | 2 | 2016 | 1137 | 0.030 |
Why?
|
| Sexism | 1 | 2016 | 51 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 77 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 999 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 361 | 0.030 |
Why?
|
| Geography | 1 | 2016 | 223 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2016 | 144 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 33 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 41 | 0.030 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2014 | 16 | 0.030 |
Why?
|
| Air Pollutants | 1 | 2016 | 78 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 696 | 0.030 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2014 | 14 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2014 | 38 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 15 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2018 | 434 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 39 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 365 | 0.030 |
Why?
|
| Population Groups | 1 | 2014 | 41 | 0.030 |
Why?
|
| Indazoles | 1 | 2014 | 68 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 937 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 369 | 0.030 |
Why?
|
| Probability | 1 | 2015 | 355 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2014 | 205 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 48 | 0.030 |
Why?
|
| Research Design | 1 | 1997 | 594 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 171 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 165 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 34 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 21 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 122 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2013 | 79 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 6501 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 80 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2012 | 28 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2016 | 425 | 0.030 |
Why?
|
| Africa | 1 | 2012 | 98 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 87 | 0.030 |
Why?
|
| Bias | 1 | 2013 | 127 | 0.030 |
Why?
|
| Canada | 1 | 2012 | 204 | 0.030 |
Why?
|
| Markov Chains | 1 | 2012 | 125 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2013 | 260 | 0.030 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2011 | 12 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 425 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2011 | 63 | 0.020 |
Why?
|
| Family | 1 | 2013 | 311 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 1924 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 106 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3636 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 526 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 456 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 350 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 1139 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 3675 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 426 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2012 | 7990 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 576 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2011 | 154 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2012 | 170 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2009 | 32 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1195 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3092 | 0.020 |
Why?
|
| Pedigree | 1 | 2011 | 966 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2232 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 621 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 689 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2009 | 124 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1577 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 174 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2261 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 8477 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2009 | 534 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2003 | 183 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2003 | 183 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1999 | 153 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1999 | 238 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 1999 | 454 | 0.010 |
Why?
|